You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage IIIC primary peritoneal cavity cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Brenner Tumor, Malignant Ascites, Malignant Pleural Effusion Trial in United States (metformin HCl, , Chemotherapy)

Suspended
  • Brenner Tumor
  • +27 more
  • metformin hydrochloride
  • +2 more
  • Birmingham, Alabama
  • +9 more
May 16, 2022

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Tumor, Fallopian Tube Mucinous Tumor Trial in Rochester

Active, not recruiting
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +22 more
  • Laboratory Biomarker Analysis
  • Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
  • Rochester, Minnesota
    Mayo Clinic
Oct 7, 2022

Stage III Fallopian Tube Cancer AJCC v7, Stage III Ovarian Cancer AJCC v6 and v7, Stage III Primary Peritoneal Cancer AJCC v7

Active, not recruiting
  • Stage III Fallopian Tube Cancer AJCC v7
  • +14 more
  • Minneapolis, Minnesota
  • +1 more
Jan 27, 2023

Stage III Fallopian Tube Cancer AJCC v7, Stage III Ovarian Cancer AJCC v6 and v7, Stage III Primary Peritoneal Cancer AJCC v7

Active, not recruiting
  • Stage III Fallopian Tube Cancer AJCC v7
  • +14 more
  • Houston, Texas
  • +4 more
Oct 20, 2022

Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer Trial in

Completed
  • Recurrent Fallopian Tube Cancer
  • +23 more
  • ALVAC(2)-NY-ESO-1 (M)/TRICOM vaccine
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Mar 25, 2020

Primary Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial (Huaier granule)

Not yet recruiting
  • Primary Ovarian Cancer
  • +2 more
  • Huaier granule
  • (no location specified)
Mar 29, 2023

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma Trial

Recruiting
  • Fallopian Tube Endometrioid Adenocarcinoma
  • +32 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Sep 16, 2022

Stage III Fallopian Tube Cancer AJCC v7, Stage III Ovarian Cancer AJCC v6 and v7, Stage III Primary Peritoneal Cancer AJCC v7

Active, not recruiting
  • Stage III Fallopian Tube Cancer AJCC v7
  • +14 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 24, 2022

BRCA-Mutated Ovarian Carcinoma, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Houston (Chemotherapy, Olaparib, Therapeutic

Recruiting
  • BRCA-Mutated Ovarian Carcinoma
  • +30 more
  • Houston, Texas
    M D Anderson Cancer Center
May 27, 2022

Stage II Fallopian Tube Cancer AJCC v8, Stage II Ovarian Cancer AJCC v8, Stage II Primary Peritoneal Cancer AJCC v8 Trial in

Not yet recruiting
  • Stage II Fallopian Tube Cancer AJCC v8
  • +33 more
  • Alpha-type-1 Polarized Dendritic Cells
  • Autologous Natural Killer Cell-like CTLs
  • Buffalo, New York
    Roswell Park Cancer Institute
Apr 1, 2022

Stage III Fallopian Tube Cancer, Stage III Ovarian Cancer, Stage III Primary Peritoneal Cancer Trial in Seattle (drug,

Terminated
Has Results
  • Stage III Fallopian Tube Cancer
  • +14 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 17, 2021

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +51 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Mar 15, 2022

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in New York (NY-ESO-1 peptide vaccine)

Completed
Has Results
  • Fallopian Tube Cancer
  • +2 more
  • NY-ESO-1 peptide vaccine
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Oct 3, 2022

Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Stage III Primary Peritoneal Cancer Trial (Cisplatin, No treatment)

Not yet recruiting
  • Stage III Ovarian Cancer
  • +5 more
  • (no location specified)
Dec 12, 2022

Ovarian Cancer, Fallopian Tube Carcinoma, Peritoneal Carcinoma Trial in Italy (carboplatin and paclitaxel followed by surgery)

Active, not recruiting
  • Ovarian Cancer
  • +2 more
  • carboplatin and paclitaxel followed by surgery
  • Bologna, Italy
  • +4 more
Dec 28, 2022

Fallopian Tube Serous Adenocarcinoma, High Grade Ovarian Serous Adenocarcinoma, Ovarian Mass Trial in United States (Laboratory

Completed
  • Fallopian Tube Serous Adenocarcinoma
  • +18 more
  • Laboratory Biomarker Analysis
  • BMN 673
  • Houston, Texas
  • +5 more
Feb 11, 2022

Advanced Breast Carcinoma, Advanced Endometrial Carcinoma, Advanced Fallopian Tube Carcinoma Trial in Houston (biological, drug,

Recruiting
  • Advanced Breast Carcinoma
  • +73 more
  • Atezolizumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
May 5, 2022

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in New York (biological, drug, other)

Completed
  • Fallopian Tube Cancer
  • +2 more
  • filgrastim
  • +3 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Aug 5, 2021

Ovarian Cancer Trial in Shanghai (Etoposide, Cyclophosphamide, Carboplatin)

Active, not recruiting
  • Ovarian Cancer
  • Etoposide, Cyclophosphamide, Carboplatin
  • Shanghai, Shanghai, China
    Wu Xiaohua
Jul 25, 2022

Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Epithelial Ovarian Cancer Trial in Baltimore (procedure, drug, other)

Recruiting
  • Stage III Ovarian Cancer
  • +6 more
  • Cytoreductive Surgery (CRS)
  • +6 more
  • Baltimore, Maryland
    Mercy Medical Center
Aug 30, 2022

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma, Ovarian Endometrioid Adenocarcinoma

Recruiting
  • Fallopian Tube Endometrioid Adenocarcinoma
  • +17 more
  • Biopsy
  • +3 more
  • Augusta, Georgia
  • +4 more
Jan 25, 2023

Advanced Fallopian Tube Carcinoma, Advanced Ovarian Carcinoma, Advanced Primary Peritoneal Carcinoma Trial in Portland (Wee1

Not yet recruiting
  • Advanced Fallopian Tube Carcinoma
  • +10 more
  • Wee1 Inhibitor ZN-c3
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jan 25, 2023

Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

Not yet recruiting
  • Platinum-Resistant Fallopian Tube Carcinoma
  • +6 more
  • Biopsy
  • Pegylated SN-38 Conjugate PLX038
  • Rochester, Minnesota
    Mayo Clinic
Jul 19, 2022

Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma, Stage I Ovarian Cancer Trial in Buffalo (procedure, drug, other)

Completed
  • Fallopian Tube Carcinoma
  • +14 more
  • Diagnostic Microscopy
  • +2 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 5, 2021

FIGO Stage III and IV Ovarian Cancer, FIGO Stage III and IV Fallopian Tube Cancer, FIGO Stage III Primary Peritoneal Cancer

Completed
  • FIGO Stage III and IV Ovarian Cancer
  • +2 more
  • ALT-803 Subcutaneous
  • ALT-803 Intraperitoneal
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Oct 5, 2022